ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print March 1, 2007, 10.1183/09031936.00075806
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dreher, M.
Right arrow Articles by Windisch, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dreher, M.
Right arrow Articles by Windisch, W.
Eur Respir J 2007; 29:930-936
Copyright ©ERS Journals Ltd 2007

Noninvasive ventilation during walking in patients with severe COPD: a randomised cross-over trial

M. Dreher, J. H. Storre and W. Windisch

Dept of Pneumology, University Hospital Freiburg, Germany.

CORRESPONDENCE: W. Windisch, Dept of Pneumology, University Hospital Freiburg, Killianstrasse 5, D-79106 Freiburg, Germany. Fax: 49 7612703704. E-mail: wolfram.windisch{at}uniklinik-freiburg.de

Keywords: Dyspnoea, exercise, 6-min walking test, noninvasive positive-pressure ventilation, oxygenation, respiratory failure

Received: June 11, 2006
Accepted January 19, 2007

It was hypothesised that noninvasive positive-pressure ventilation (NPPV) applied during walking prevents exercise-induced hypoxaemia and improves exercise performance in severe chronic obstructive pulmonary disease (COPD) patients already receiving long-term NPPV.

A total of 20 COPD patients (mean±SD age 65.1±8.7 yrs, forced expiratory volume in one second 27±8% predicted and total lung capacity 116±27% pred) reporting dyspnoea, even during mild exertion, underwent two 6-min walking tests with a rollator and supplemental oxygen (2.1±0.9 L·min–1) in a randomised cross-over design: with and without pressure-limited NPPV as used at home (inspiratory:expiratory pressure 2.9±0.44:0.4±0.1 kPa (29±4:4±1 mbar), respiratory frequency 20±2 breaths·min–1).

The arterial oxygen tension significantly increased by 1.39±1.43 kPa (95% confidence interval (CI) 0.71–2.07 kPa) after walking with NPPV, but significantly decreased by 1.43±1.06 kPa (95% CI –1.92 – –0.94 kPa) without NPPV. Dyspnoea, as assessed by the Borg dyspnoea scale, significantly decreased from 6 (interquartile range (IQR) 4.5–10) to 4 (1.5–4.5) and walking distance significantly increased from 209 (IQR 178–279) to 252 (203–314) m when walking was NPPV-aided.

In chronic hypercapnic chronic obstructive pulmonary disease, high-intensity noninvasive positive-pressure ventilation can also be administered during walking with unchanged ventilator settings compared with settings used at rest, thus resulting in improved oxygenation, decreased dyspnoea and increased walking distance. Therefore, noninvasive positive-pressure ventilation during walking could prevent hypoxia-induced complications and could, in future, play a role in palliative care.




This article has been cited by other articles:


Home page
Eur Respir JHome page
E. M. Clini and N. Ambrosino
Nonpharmacological treatment and relief of symptoms in COPD
Eur. Respir. J., July 1, 2008; 32(1): 218 - 228.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the European Respiratory Society.